Epilepsy Clinical Trials in Cleveland, Ohio

6 studies are recruiting for epilepsy in Cleveland, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

   The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. Thi…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   University Hospitals Cleveland Medical Center, Cleveland, Ohio

   Locations

   18 in total

   Run by

   Epiminder America, Inc.

   See if you can join NCT07110454 on ClinicalTrials.gov

2. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

   This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Cleveland Clinic, Cleveland, Ohio

   Locations

   11 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07563881 on ClinicalTrials.gov

3. Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery

   The goal of this clinical trial is to learn if new educational program prior to epilepsy surgery can either decrease the risk of cognitive decline after surgery or be a help to those patients who experience a decline after undergoing epilepsy surgery. Participants will participate in 2 individual v…

   Stage

   Not phased

   Ages

   18 to 60

   Site

   Cleveland Clinic, Cleveland, Ohio

   Run by

   Kayela Arrotta

   See if you can join NCT05992402 on ClinicalTrials.gov

4. Healthy Aging in People With Epilepsy Program

   The goal of this clinical trial is to develop and test an educational program about dementia in older adults living with epilepsy. The main questions it aims to answer are: 1. Can providing education on healthy aging, chronic disease management, dementia, and modifiable lifestyle dementia risk fact…

   Stage

   Not phased

   Ages

   55 to 90

   Site

   Cleveland Clinic, Cleveland, Ohio

   Run by

   Anny Reyes

   See if you can join NCT06052605 on ClinicalTrials.gov

5. Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes

   The goal of this study is to identify the needs and barriers to accessing and undergoing epilepsy surgery for patients with epilepsy and then to pilot an educational program regarding the social determinants of health and how they can influence surgical rates and epilepsy outcomes. For the first pa…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cleveland Clinic, Cleveland, Ohio

   Run by

   Anny Reyes

   See if you can join NCT07509190 on ClinicalTrials.gov

6. A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

   This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   Cleveland Clinic Foundation, Cleveland, Ohio

   Locations

   7 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07219407 on ClinicalTrials.gov